Physician profile
Marco Amendola
NPI 1922031095
$56,264.86
in general payments reported to CMS, 2019-2025
9 companies · $9,428 in 2025
The $9,428 reported for 2025 was more than what 92% of Body Imaging providers received nationally (typical 2025 total: $84.96).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,542 · 2020: $136 · 2021: $37.40 · 2022: $11K · 2023: $20K · 2024: $14K · 2025: $9,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,494.40 |
| Food and Beverage | $228.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $53,296.19 | 2019-2025 | Truebeam, Edge, Varian Ethos Treatment Planning |
| Varian Medical Systems, INC. | $2,498.07 | 2019-2020 | |
| Blue Earth Diagnostics | $149.40 | 2021-2024 | |
| Novocure INC. | $85.49 | 2020 | |
| Canon Medical Informatics, INC. | $80.02 | 2019 | |
| Progenics Pharmaceuticals, INC. | $43.72 | 2024 | |
| Telix Pharmaceuticals | $39.93 | 2024 | Illuccix |
| Chiesi USA, INC. | $39.01 | 2022 | |
| Lundbeck LLC | $33.03 | 2024 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Amendola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.